Calumet Inc
CLMT
56.29
+0.08
+0.14%
Calumet Inc
US · CLMT
#2145 by market cap
Listed 1970
56.29
+0.08
+0.14%
Live - 5344 symbols - heartbeat 280s ago
· 2026-10-08 07:00
Pre-market
57.60
+2.33%
After-hours
56.29
0.00%
Overnight
55.39
-1.60%
- Market cap
- 4.95B
- P/E (TTM)i
- -36.55
- P/Bi
- -4.35
- EPSi
- -0.39
- Div yieldi
- 0.00%
- 52W posi
- 92%
Reader sentiment
Are you bullish or bearish on CLMT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 70.45% +0.07pp
- Institutions
- 229
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund28.88%
Private Company19.26%
Hedge Fund12.15%
Public Company4.97%
Family Office/Trust4.54%
Individual/Insider3.41%
Government Pension Fund0.53%
Insurance Company0.10%
Other26.14%
Top holders
The Heritage Group
16.52%
Two Seas Capital LP
7.53%
BlackRock
5.95%
Wasserstein & Co., L.P.
4.51%
Vanguard Capital Management, LLC
4.47%
State Street Global Advisors
3.95%
Adams Asset Advisors LLC
2.28%
Geode Capital Management, LLC
2.23%
Barclays PLC
1.60%
Vanguard Portfolio Management, LLC
1.17%
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 38 buys · 12 sells
| Name | Role | Stake |
|---|---|---|
| The Heritage Group | -- | 16.52% |
| Jennifer Straumins | Director of Calumet GP, LLC | 1.07% |
| Bruce Fleming | Executive Vice President of Montana Renewables & Corporate Development of Calumet GP, LLC | 0.70% |
| Stephen Mawer | Chairman of the Board of Calumet GP, LLC | 0.40% |
| Louis Borgmann | Chief Executive Officer of Calumet GP, LLC | 0.37% |
| Amy Schumacher | Director of Calumet GP, LLC | 0.29% |
| Scott Obermeier | Executive Vice President of Specialties of Calumet GP, LLC | 0.27% |
| Daniel Sajkowski | Director of Calumet GP, LLC | 0.09% |
| Gregory Morical | Senior VP, General Counsel & Secretary of Calumet GP, LLC | 0.07% |
| John Boss | Independent Director of Calumet GP, LLC | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-24 | Stephen Mawer | Chairman of the Board of Calumet GP, LLC | Derivative Exercise and Sale | -24,555 | -- |
| 2026-09-24 | Stephen Mawer | Chairman of the Board of Calumet GP, LLC | Derivative Exercise and Retained | +36,832 | -- |
| 2026-09-24 | Bruce Fleming | Executive Vice President of Montana Renewables & Corporate Development of Calumet GP, LLC | Derivative Exercise and Sale | -42,190 | -- |
| 2026-09-24 | Bruce Fleming | Executive Vice President of Montana Renewables & Corporate Development of Calumet GP, LLC | Derivative Exercise and Retained | +65,238 | -- |
| 2026-09-24 | Louis Borgmann | Chief Executive Officer of Calumet GP, LLC | Derivative Exercise and Sale | -46,901 | -- |
| 2026-09-24 | Louis Borgmann | Chief Executive Officer of Calumet GP, LLC | Derivative Exercise and Retained | +60,527 | -- |
| 2026-09-24 | Gregory Morical | Senior VP, General Counsel & Secretary of Calumet GP, LLC | Derivative Exercise and Sale | -13,560 | -- |
| 2026-09-24 | Gregory Morical | Senior VP, General Counsel & Secretary of Calumet GP, LLC | Derivative Exercise and Retained | +17,134 | -- |
| 2026-08-19 | John Boss | Independent Director of Calumet GP, LLC | Other Derivative Acquisition | +53 | -- |
| 2026-08-19 | John Boss | Independent Director of Calumet GP, LLC | Other Derivative Acquisition | +160 | -- |
| 2026-08-19 | Paul Raymond | Director of Calumet GP, LLC | Other Derivative Acquisition | +178 | -- |
| 2026-08-19 | Paul Raymond | Director of Calumet GP, LLC | Other Derivative Acquisition | +534 | -- |
| 2026-08-19 | Stephen Mawer | Chairman of the Board of Calumet GP, LLC | Other Derivative Acquisition | +230 | -- |
| 2026-08-19 | Stephen Mawer | Chairman of the Board of Calumet GP, LLC | Other Derivative Acquisition | +690 | -- |
| 2026-08-19 | Amy Schumacher | Director of Calumet GP, LLC | Other Derivative Acquisition | +162 | -- |
| 2026-08-19 | Amy Schumacher | Director of Calumet GP, LLC | Other Derivative Acquisition | +488 | -- |
| 2026-07-08 | Karen Narwold | Independent Director | Derivative Exercise and Retained | +7,067 | -- |
| 2026-07-08 | Karen Twitchell | Independent Director of Calumet GP, LLC | Derivative Exercise and Retained | +7,067 | -- |
| 2026-07-08 | John Boss | Independent Director of Calumet GP, LLC | Derivative Exercise and Sale | -2,827 | -- |
| 2026-07-08 | John Boss | Independent Director of Calumet GP, LLC | Derivative Exercise and Retained | +4,240 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:00:08 · For reference only, not investment advice and not tailored to your situation.